Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SWK Holdings Corp SWKH

Alternate Symbol(s):  SWKHL

Financial Services
SWK Holdings Corporation is engaged in specialty finance and asset management business. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash... see more

Recent & Breaking News (NDAQ:SWKH)

Enteris BioPharma's Licensing Partner, Cara Therapeutics, Announces Top Line Data from Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA(TM) for the Treatment of Pruritus in Patients with Advanced Chronic Kidney Disease (CKD)

PR Newswire December 6, 2019

SWK Holdings Elects CEO Winston Black as New Chairman of the Board

PR Newswire November 21, 2019

SWK Holdings Corporation Announces 2019 Third Quarter Financial Results

PR Newswire November 18, 2019

SWK Holdings to Present at the Fall Investor Summit

PR Newswire September 16, 2019

SWK Holdings Corporation Resumes Share Repurchase Program

PR Newswire September 6, 2019

SWK Holdings Corporation Files Application for Uplisting to NASDAQ Capital Market

PR Newswire September 3, 2019

SWK Holdings Corporation Acquires Enteris BioPharma

PR Newswire August 27, 2019

SWK Holdings Corporation Announces 2019 Second Quarter Financial Results

GlobeNewswire August 12, 2019

Harrow Health Announces Renegotiated Debt Facility with SWK Holdings

GlobeNewswire May 29, 2019

SWK Holdings Corporation Announces 2018 Fourth Quarter and Full-Year Financial Results

GlobeNewswire March 29, 2019

SWK Holdings Corporation Announces Share Repurchase Program

GlobeNewswire December 6, 2018

SWK Holdings Corporation Announces 2018 Third Quarter Financial Results

GlobeNewswire November 12, 2018

SWK Holdings Corporation Announces 2018 Second Quarter Financial Results

GlobeNewswire August 10, 2018

SWK Holdings Corporation Closes $20 Million Revolving Loan Facility with AloStar Capital Finance

GlobeNewswire July 2, 2018

SWK Holdings Corporation Announces 2018 First Quarter Financial Results

GlobeNewswire May 15, 2018

SWK Holdings Corporation Announces 2017 Fourth Quarter and Full-Year Financial Results

GlobeNewswire March 29, 2018

SWK Holdings Corporation Announces 2017 Third Quarter Financial Results

GlobeNewswire November 10, 2017

Imprimis Pharmaceuticals Announces $16 Million Debt Facility with SWK Holdings

PR Newswire July 20, 2017

SWK Holdings Corporation Announces 2017 First Quarter Financial Results

GlobeNewswire May 11, 2017

SWK Holdings Corporation Announces 2016 Fourth Quarter and Full-Year Financial Results

GlobeNewswire March 20, 2017